查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1537019

PET放射性描繪器市場:全球產業分析，規模，佔有率，成長，趨勢，預測，2024年～2033年

PET Radioactive Tracers Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 359 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research最近發布了一份關於全球 PET 放射性追蹤劑市場的綜合報告。這種深入的分析提供了對市場動態的重要見解，包括驅動因素、趨勢、機會和挑戰，並提供了對市場結構的完整了解。

主要的洞察

  • PET放射性示蹤劑市場規模（2024年）：10.539億美元
  • 市場預測金額（2033 年）：19.263 億美元
  • 全球市場成長率（2024-2033 年複合年增長率）：6.9%

PET放射性示蹤劑市場：研究範圍

PET 放射性追蹤劑市場涵蓋用於正子斷層掃描 (PET) 影像的各種產品，用於檢測和監測各種疾病。該市場包括不同類型的 PET 放射性追蹤劑，例如氟脫氧葡萄糖 (FDG)、氨和膽鹼，這些對於準確的影像診斷至關重要。該市場面向醫院、影像診斷中心、研究機構等不同細分市場，並透過直銷、網路平台、醫療用品經銷商等管道進行分銷。影像技術的進步、慢性病的增加以及對早期疾病檢測和個人化醫療的需求不斷增長推動了成長。

推動市場成長的因素：

有幾個因素促進了全球 PET 放射性追蹤劑市場的成長。 PET 影像和放射性追蹤劑開發的技術進步提高了診斷能力和準確性。癌症、心血管疾病和神經系統疾病等慢性病的盛行率不斷上升，將推動對 PET 影像用於早期診斷和治療監測的需求。此外，對個人化醫療和精準診斷的日益關注正在推動 PET 放射性追蹤劑的採用。醫療保健基礎設施和研發投資的增加也推動了市場擴張。

市場限制因素：

儘管 PET 放射性追蹤劑市場具有成長潛力，但仍面臨 PET 影像和放射性追蹤劑高成本的挑戰。放射性材料的監管限制和嚴格的安全標準使市場運作變得複雜。此外，PET 影像處理對專業基礎設施和訓練有素的人員的需求也影響著市場。來自替代成像技術的競爭和分子成像的進步也可能對市場成長構成挑戰。解決這些問題需要專注於降低成本、合規性和持續創新。

市場機會：

由於精準醫療的發展趨勢和影像技術的進步，PET 放射性示蹤劑市場提供了龐大的商機。開發具有增強診斷能力的新型放射性示蹤劑市場具有擴大市場的潛力。由於慢性病的增加和人口老化，對 PET 影像服務的需求不斷增加。向新興市場的擴張以及遠距醫療和遠距診斷的成長將為成長開闢新的途徑。策略夥伴關係、研發投資以及採用創新示蹤配方對於利用新機會和維持市場領先地位至關重要。

本報告解決的關鍵問題

  • 推動全球 PET 放射性追蹤劑市場成長的關鍵因素是什麼？
  • 各種診斷環境中採用哪些類型和應用的 PET 放射性追蹤劑？
  • 技術進步如何影響 PET 放射性追蹤劑市場的競爭格局？
  • 誰是 PET 放射性追蹤劑市場的主要參與者？
  • 全球PET放射性示蹤劑市場的新趨勢和未來前景是什麼？

目錄

第1章 摘要整理

第2章 市場概要

  • 市場範圍/分類
  • 市場定義/範圍/限制
  • 蘊藏事項·除外事項

第3章 主要市場趨勢

  • 影響市場的主要趨勢
  • 革新/開發趨勢

第4章 主要成功因素

  • PET掃描儀的用戶數(裝置量)情境
  • PET掃描數:各國
  • 疾病流行病學
  • 產品的採用/使用情形分析
  • 法規核準的途徑
  • 退還情境
  • 技術的進步
  • 合理製造規範(cGMP)
  • 價值鏈分析
  • 質量標準/檢定
  • PESTEL分析
  • 波特分析

第5章 市場背景

  • 宏觀經濟要素
  • 預測要素 - 相關性及影響
  • 市場動態

第6章 COVID-19危機分析

  • 2024年的市場情境
  • COVID-19及影響分析
    • 各產品
    • 各用途
    • 各終端用戶
    • 各地區

第7章 全球市場的需求(金額或規模，一百萬美元)分析

  • 過去的市場金額(一百萬美元)分析，2019年～2023年
  • 現在及未來市場金額(一百萬美元)預測，2024年～2033年
    • 與前一年同期比較成長趨勢分析
    • 絕對額的機會分析

第8章 全球市場分析:各產品

  • 簡介/主要調查結果
  • 過去的市場規模(一百萬美元)的分析:各產品，2019年～2023年
  • 現在及未來市場規模(一百萬美元)分析與預測:各產品，2024年～2033年
    • F-18
    • C-11
    • Ga-68
    • O-15
    • N-13
    • Cu-64
  • 市場魅力分析:各終端用戶

第9章 全球市場分析:各用途

  • 簡介/主要調查結果
  • 過去的市場規模(一百萬美元)的分析:各用途，2019年～2023年
  • 現在及未來市場規模(一百萬美元)的分析與預測:各用途，2024年～2033年
    • 神經疾病
    • 癌症的診斷和預後
    • 心臟功能障礙
    • 感染疾病的診斷
    • 其他
  • 市場魅力分析:各用途

第10章 全球市場分析:各終端用戶

  • 簡介/主要調查結果
  • 過去的市場規模(一百萬美元)的分析:各終端用戶，2019年～2023年
  • 現在及未來市場規模(一百萬美元)的分析與預測:各終端用戶，2024年～2033年
    • 醫院
    • 專門診斷中心
    • 癌症研究中心
    • 學術調查機關
  • 市場魅力分析:各終端用戶

第11章 全球市場分析:各地區

  • 簡介
  • 過去的市場規模(一百萬美元)的分析:各地區，2019年～2023年
  • 現在及未來市場規模(一百萬美元)的分析與預測:各地區，2024年～2033年
    • 北美
    • 南美
    • 東亞
    • 南亞·太平洋
    • 西歐
    • 東歐
    • 中亞
    • 俄羅斯·白俄羅斯
    • 巴爾幹半島·波羅的海三小國
    • 中東·非洲
  • 市場魅力分析:各地區

第12章 北美市場分析

第13章 南美市場分析

第14章 東亞市場分析

第15章 南亞·太平洋市場分析

第16章 西歐市場分析

第17章 東歐市場分析

第18章 中亞市場分析

第19章 俄羅斯·白俄羅斯市場分析

第20章 巴爾幹半島·波羅的海三小國市場分析

第21章 中東·非洲(MEA)市場分析

第22章 市場結構分析

  • 市場分析:企業各層級
  • 主要企業的市場佔有率分析
  • 市場影響分析

第23章 競爭分析

  • 競爭儀表板
  • 競爭基準
  • 競爭的詳細資訊
    • Eli Lilly and Company
    • Blue Earth Diagnostics
    • Lantheus
    • Siemens Healthcare Private Limited
    • GE Healthcare
    • Advanced Accelerator Applications(Novartis)
    • University of Lowa HealthCare
    • Telix Pharmaceuticals Limited
    • Jubilant Radiopharma
    • TRASIS
    • RadioMedix Inc.
    • IBA Radiopharma Solutions
    • Piramal Imaging(Life Molecular Imaging)
    • Cardinal Health
    • DuchemBio, Co., Ltd

第24章 所使用的前提條件與縮寫

第25章 調查手法

簡介目錄
Product Code: PMRREP33446

Persistence Market Research has recently released a comprehensive report on the global PET Radioactive Tracers Market. This detailed analysis provides critical insights into the market dynamics, including drivers, trends, opportunities, and challenges, offering a thorough understanding of the market structure.

Key Insights:

  • PET Radioactive Tracers Market Size (2024E): USD 1,053.9 Million
  • Projected Market Value (2033F): USD 1,926.30 Million
  • Global Market Growth Rate (CAGR 2024 to 2033): 6.9%

PET Radioactive Tracers Market - Report Scope:

The PET Radioactive Tracers Market covers a range of products utilized in positron emission tomography (PET) imaging to detect and monitor various diseases. This market includes different types of PET radioactive tracers, such as fluorodeoxyglucose (FDG), ammonia, and choline, essential for accurate diagnostic imaging. The market caters to diverse segments including hospitals, diagnostic imaging centers, and research institutions, distributed through channels like direct sales, online platforms, and medical supply distributors. Growth is driven by advancements in imaging technology, increasing prevalence of chronic diseases, and rising demand for early disease detection and personalized medicine.

Market Growth Drivers:

Several factors contribute to the growth of the global PET Radioactive Tracers Market. Technological advancements in PET imaging and radioactive tracer development enhance diagnostic capabilities and accuracy. The increasing prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions drives the demand for PET imaging for early diagnosis and treatment monitoring. Furthermore, the rising focus on personalized medicine and precision diagnostics boosts the adoption of PET radioactive tracers. Increased investments in healthcare infrastructure and research and development also fuel market expansion.

Market Restraints:

Despite its growth potential, the PET Radioactive Tracers Market faces challenges related to the high cost of PET imaging and radioactive tracers, which can limit their accessibility and adoption. Regulatory constraints and stringent safety standards for radioactive materials add complexity to market operations. Additionally, the market is impacted by the need for specialized infrastructure and trained personnel for PET imaging procedures. Competition from alternative imaging techniques and advancements in molecular imaging may also pose challenges to market growth. Addressing these issues requires a focus on cost reduction, regulatory compliance, and ongoing innovation.

Market Opportunities:

The PET Radioactive Tracers Market presents significant opportunities driven by the growing trend of precision medicine and advancements in imaging technologies. The development of new and improved radioactive tracers with enhanced diagnostic capabilities offers potential for market expansion. The rising prevalence of chronic diseases and an aging population increase the demand for PET imaging services. Expansion into emerging markets and the growth of telemedicine and remote diagnostics present new avenues for growth. Strategic partnerships, investments in R&D, and the introduction of innovative tracer formulations are essential for capitalizing on emerging opportunities and maintaining market leadership.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the PET Radioactive Tracers Market globally?
  • Which types and applications of PET radioactive tracers are leading the adoption in various diagnostic settings?
  • How are technological advancements influencing the competitive landscape of the PET Radioactive Tracers Market?
  • Who are the key players in the PET Radioactive Tracers Market, and what strategies are they employing to stay competitive?
  • What are the emerging trends and future prospects in the global PET Radioactive Tracers Market?

Competitive Intelligence and Business Strategy:

Leading players in the global PET Radioactive Tracers Market, including GE Healthcare, Siemens Healthineers, and Philips Healthcare, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest in R&D to develop advanced radioactive tracers and imaging technologies, such as PET-CT and PET-MRI systems. Collaborations with research institutions, hospitals, and diagnostic centers facilitate market access and promote new product adoption. Emphasis on regulatory compliance, high-quality products, and comprehensive marketing strategies fosters market growth and enhances brand loyalty in the evolving PET Radioactive Tracers Market landscape.

Key Companies Profiled:

  • Eli Lilly and Company
  • Blue Earth Diagnostics
  • Lantheus
  • Siemens Healthcare Private Limited
  • GE Healthcare
  • Advanced Accelerator Applications (Novartis)
  • University of Lowa HealthCare
  • Telix Pharmaceuticals Limited
  • Jubilant Radiopharma
  • TRASIS
  • RadioMedix Inc.
  • IBA Radiopharma Solutions
  • Piramal Imaging (Life Molecular Imaging)
  • Cardinal Health
  • DuchemBio, Co. Ltd.

PET Radioactive Tracers Market Industry Segmentation

By Product Type:

  • F-18
  • C-11
  • Ga-68
  • O-15
  • N-13
  • Cu-64

By Applications

  • Neurological Disorders
  • Cancer Diagnosis & Prognosis
  • Cardiac Dysfunctions
  • Infectious Disease Diagnosis
  • Others

By End User:

  • Hospitals
  • Speciality Diagnostic Centers
  • Cancer Research Centers
  • Academic & Research Institutes

By Region:

  • North America
  • Latin America
  • East Asia
  • South Asia & Pacific
  • Western Europe
  • Eastern Europe
  • Central Asia
  • Russia & Belarus
  • Balkan & Baltic Countries
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusion and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Innovation / Development Trends

4. Key Success Factors

  • 4.1. PET Scanner Installed Base Scenario
  • 4.2. Number of PET Scans, By Country
  • 4.3. Disease Epidemiology
  • 4.4. Product Adoption/Usage Analysis
  • 4.5. Regulatory Approval Pathway
  • 4.6. Reimbursement Scenario
  • 4.7. Technology Advancements
  • 4.8. Good Manufacturing Practice (cGMP)
  • 4.9. Value Chain Analysis
  • 4.10. Quality Standards/Accreditations
  • 4.11. PESTEL Analysis
  • 4.12. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Outlook
    • 5.1.2. Global Healthcare Expenditure Outlook
    • 5.1.3. Oncology Spending
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Development of Novel Products
    • 5.2.2. Regulatory Imposition
    • 5.2.3. Increasing Spending on Targeted Therapies
    • 5.2.4. Increasing Prevalence of Cancer
    • 5.2.5. Strategic Mergers and Acquisitions among Local Players
    • 5.2.6. Rising Awareness towards Development of Disease
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. 2024 Market Scenario
  • 6.2. COVID-19 and Impact Analysis
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Region

7. Global Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Product, 2019-2023
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2024-2033
    • 8.3.1. F-18
      • 8.3.1.1. Florbetapir
      • 8.3.1.2. Florbetaben
      • 8.3.1.3. Flutemetamol
      • 8.3.1.4. Fludeoxyglucose
      • 8.3.1.5. Sodium Fluoride
      • 8.3.1.6. Others
    • 8.3.2. C-11
      • 8.3.2.1. Choline
      • 8.3.2.2. Methionine
      • 8.3.2.3. Others
    • 8.3.3. Ga-68
      • 8.3.3.1. DOTA-TOC
      • 8.3.3.2. DOTATATE
      • 8.3.3.3. DOTANOC
      • 8.3.3.4. Others
    • 8.3.4. O-15
    • 8.3.5. N-13
    • 8.3.6. Cu-64
  • 8.4. Market Attractiveness Analysis By End User

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Application

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis By Application, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2024-2033
    • 9.3.1. Neurological Disorders
      • 9.3.1.1. Alzheimer's Disease
      • 9.3.1.2. Dementia
      • 9.3.1.3. Others
    • 9.3.2. Cancer Diagnosis & Prognosis
      • 9.3.2.1. Solid Tumor
      • 9.3.2.2. Hematology Tumor
    • 9.3.3. Cardiac Dysfunctions
      • 9.3.3.1. Myocardial Infarction
      • 9.3.3.2. Others
    • 9.3.4. Infectious disease Diagnosis
    • 9.3.5. Others
  • 9.4. Market Attractiveness Analysis By Application

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2033
    • 10.3.1. Hospitals
    • 10.3.2. Speciality Diagnostic Centers
    • 10.3.3. Cancer Research Centers
    • 10.3.4. Academic & Research Institutes
  • 10.4. Market Attractiveness Analysis By End User

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2024-2033
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. East Asia
    • 11.3.4. South Asia & Pacific
    • 11.3.5. Western Europe
    • 11.3.6. Eastern Europe
    • 11.3.7. Central Asia
    • 11.3.8. Russia & Belarus
    • 11.3.9. Balkan & Baltic Countries
    • 11.3.10. Middle East & Africa
  • 11.4. Market Attractiveness Analysis By Region

12. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Product
    • 12.3.3. By Application
    • 12.3.4. By End User
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Product
    • 12.4.3. By Application
    • 12.4.4. By End User
  • 12.5. Key Market Trends
  • 12.6. Drivers and Restraints - Impact Analysis
  • 12.7. Key Players - Intensity Mapping
  • 12.8. Country Level Analysis & Forecast
    • 12.8.1. U.S. Market
      • 12.8.1.1. Introduction
      • 12.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.1.2.1. By Product
        • 12.8.1.2.2. By Application
        • 12.8.1.2.3. By End User
    • 12.8.2. Canada Market
      • 12.8.2.1. Introduction
      • 12.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.2.2.1. By Product
        • 12.8.2.2.2. By Application
        • 12.8.2.2.3. By End User

13. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. Brazil
      • 13.3.1.2. Argentina
      • 13.3.1.3. Mexico
      • 13.3.1.4. Rest of Latin America
    • 13.3.2. By Product
    • 13.3.3. By Application
    • 13.3.4. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Product
    • 13.4.3. By Application
    • 13.4.4. By End User
  • 13.5. Key Market Trends
  • 13.6. Drivers and Restraints - Impact Analysis
  • 13.7. Key Players - Intensity Mapping
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. Brazil Market
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.1.2.1. By Product
        • 13.8.1.2.2. By Application
        • 13.8.1.2.3. By End User
    • 13.8.2. Argentina Market
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.2.2.1. By Product
        • 13.8.2.2.2. By Application
        • 13.8.2.2.3. By End User
    • 13.8.3. Mexico Market
      • 13.8.3.1. Introduction
      • 13.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.3.2.1. By Product
        • 13.8.3.2.2. By Application
        • 13.8.3.2.3. By End User

14. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. China
      • 14.3.1.2. Japan
      • 14.3.1.3. South Korea
    • 14.3.2. By Product
    • 14.3.3. By Application
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Application
    • 14.4.4. By End User
  • 14.5. Key Market Trends
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Key Players - Intensity Mapping
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. China Market
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Product
        • 14.8.1.2.2. By Application
        • 14.8.1.2.3. By End User
    • 14.8.2. Japan Market
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Product
        • 14.8.2.2.2. By Application
        • 14.8.2.2.3. By End User
    • 14.8.3. South Korea Market
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.3.2.1. By Product
        • 14.8.3.2.2. By Application
        • 14.8.3.2.3. By End User

15. South Asia & Pacific Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. India
      • 15.3.1.2. Indonesia
      • 15.3.1.3. Thailand
      • 15.3.1.4. Philippines
      • 15.3.1.5. Malaysia
      • 15.3.1.6. Vietnam
      • 15.3.1.7. Rest of ASEAN
      • 15.3.1.8. Australia & New Zealand
    • 15.3.2. By Product
    • 15.3.3. By Application
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Application
    • 15.4.4. By End User
  • 15.5. Key Market Trends
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Key Players - Intensity Mapping
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. India Market
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Product
        • 15.8.1.2.2. By Application
        • 15.8.1.2.3. By End User
    • 15.8.2. Indonesia Market
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Product
        • 15.8.2.2.2. By Application
        • 15.8.2.2.3. By End User
    • 15.8.3. Thailand Market
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Product
        • 15.8.3.2.2. By Application
        • 15.8.3.2.3. By End User
    • 15.8.4. Philippines Market
      • 15.8.4.1. Introduction
      • 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.4.2.1. By Product
        • 15.8.4.2.2. By Application
        • 15.8.4.2.3. By End User
    • 15.8.5. Malaysia Market
      • 15.8.5.1. Introduction
      • 15.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.5.2.1. By Product
        • 15.8.5.2.2. By Application
        • 15.8.5.2.3. By End User
    • 15.8.6. Vietnam Market
      • 15.8.6.1. Introduction
      • 15.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.6.2.1. By Product
        • 15.8.6.2.2. By Application
        • 15.8.6.2.3. By End User
    • 15.8.7. Australia & New Zealand Market
      • 15.8.7.1. Introduction
      • 15.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.7.2.1. By Product
        • 15.8.7.2.2. By Application
        • 15.8.7.2.3. By End User

16. Western Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. Germany
      • 16.3.1.2. France
      • 16.3.1.3. Spain
      • 16.3.1.4. Italy
      • 16.3.1.5. BENELUX
      • 16.3.1.6. Nordic Countries
      • 16.3.1.7. United Kingdom
    • 16.3.2. By Product
    • 16.3.3. By Application
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Application
    • 16.4.4. By End User
  • 16.5. Key Market Trends
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Key Players - Intensity Mapping
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. Germany Market
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Product
        • 16.8.1.2.2. By Application
        • 16.8.1.2.3. By End User
    • 16.8.2. France Market
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Product
        • 16.8.2.2.2. By Application
        • 16.8.2.2.3. By End User
    • 16.8.3. Spain Market
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.3.2.1. By Product
        • 16.8.3.2.2. By Application
        • 16.8.3.2.3. By End User
    • 16.8.4. Italy Market
      • 16.8.4.1. Introduction
      • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.4.2.1. By Product
        • 16.8.4.2.2. By Application
        • 16.8.4.2.3. By End User
    • 16.8.5. BENULUX Market
      • 16.8.5.1. Introduction
      • 16.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.5.2.1. By Product
        • 16.8.5.2.2. By Application
        • 16.8.5.2.3. By End User
    • 16.8.6. Nordic Countries Market
      • 16.8.6.1. Introduction
      • 16.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.6.2.1. By Product
        • 16.8.6.2.2. By Application
        • 16.8.6.2.3. By End User
    • 16.8.7. U.K. Market
      • 16.8.7.1. Introduction
      • 16.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.7.2.1. By Product
        • 16.8.7.2.2. By Application
        • 16.8.7.2.3. By End User

17. Eastern Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. Poland
      • 17.3.1.2. Hungary
      • 17.3.1.3. Romania
      • 17.3.1.4. Czech Republic
      • 17.3.1.5. Rest of Eastern Europe
    • 17.3.2. By Product
    • 17.3.3. By Application
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Application
    • 17.4.4. By End User
  • 17.5. Key Market Trends
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Key Players - Intensity Mapping
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. Poland Market
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Product
        • 17.8.1.2.2. By Application
        • 17.8.1.2.3. By End User
    • 17.8.2. Hungary Market
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Product
        • 17.8.2.2.2. By Application
        • 17.8.2.2.3. By End User
    • 17.8.3. Romania Market
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.3.2.1. By Product
        • 17.8.3.2.2. By Application
        • 17.8.3.2.3. By End User
    • 17.8.4. Czech Republic Market
      • 17.8.4.1. Introduction
      • 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.4.2.1. By Product
        • 17.8.4.2.2. By Application
        • 17.8.4.2.3. By End User

18. Central Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 18.3.1. By Product
    • 18.3.2. By Application
    • 18.3.3. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Product
    • 18.4.2. By Application
    • 18.4.3. By End User
  • 18.5. Key Market Trends
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Key Players - Intensity Mapping

19. Russia & Belarus Market Analysis 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 19.3.1. By Product
    • 19.3.2. By Application
    • 19.3.3. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Product
    • 19.4.2. By Application
    • 19.4.3. By End User
  • 19.5. Key Market Trends
  • 19.6. Drivers and Restraints - Impact Analysis
  • 19.7. Key Players - Intensity Mapping

20. Balkan & Baltic Countries Market Analysis 2019-2023 and Forecast 2024-2033

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 20.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 20.3.1. By Product
    • 20.3.2. By Application
    • 20.3.3. By End User
  • 20.4. Market Attractiveness Analysis
    • 20.4.1. By Product
    • 20.4.2. By Application
    • 20.4.3. By End User
  • 20.5. Key Market Trends
  • 20.6. Drivers and Restraints - Impact Analysis
  • 20.7. Key Players - Intensity Mapping

21. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

  • 21.1. Introduction
  • 21.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 21.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 21.3.1. By Country
      • 21.3.1.1. GCC Countries
      • 21.3.1.2. Kingdom of Saudi Arabia
      • 21.3.1.3. Turkiye
      • 21.3.1.4. Northern Africa
      • 21.3.1.5. South Africa
      • 21.3.1.6. Israel
    • 21.3.2. By Product
    • 21.3.3. By Application
    • 21.3.4. By End User
  • 21.4. Market Attractiveness Analysis
    • 21.4.1. By Country
    • 21.4.2. By Product
    • 21.4.3. By Application
    • 21.4.4. By End User
  • 21.5. Key Market Trends
  • 21.6. Drivers and Restraints - Impact Analysis
  • 21.7. Key Players - Intensity Mapping
  • 21.8. Country Level Analysis & Forecast
    • 21.8.1. GCC Countries Market
      • 21.8.1.1. Introduction
      • 21.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 21.8.1.2.1. By Product
        • 21.8.1.2.2. By Application
        • 21.8.1.2.3. By End User
    • 21.8.2. Kingdom of Saudi Arabia Market
      • 21.8.2.1. Introduction
      • 21.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 21.8.2.2.1. By Product
        • 21.8.2.2.2. By Application
        • 21.8.2.2.3. By End User
    • 21.8.3. Turkiye Market
      • 21.8.3.1. Introduction
      • 21.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 21.8.3.2.1. By Product
        • 21.8.3.2.2. By Application
        • 21.8.3.2.3. By End User
    • 21.8.4. Northern Africa Market
      • 21.8.4.1. Introduction
      • 21.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 21.8.4.2.1. By Product
        • 21.8.4.2.2. By Application
        • 21.8.4.2.3. By End User
    • 21.8.5. South Africa Market
      • 21.8.5.1. Introduction
      • 21.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 21.8.5.2.1. By Product
        • 21.8.5.2.2. By Application
        • 21.8.5.2.3. By End User
    • 21.8.6. Israel Market
      • 21.8.6.1. Introduction
      • 21.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 21.8.6.2.1. By Product
        • 21.8.6.2.2. By Application
        • 21.8.6.2.3. By End User

22. Market Structure Analysis

  • 22.1. Market Analysis by Tier of Companies
  • 22.2. Market Share Analysis of Top Players
  • 22.3. Market Presence Analysis
    • 22.3.1. Regional footprint of Players
    • 22.3.2. Platform Type foot print by Players
    • 22.3.3. Channel Foot Print by Players

23. Competition Analysis

  • 23.1. Competition Dashboard
  • 23.2. Competition Benchmarking
  • 23.3. Competition Deep Dive
    • 23.3.1. Eli Lilly and Company
      • 23.3.1.1. Company Overview
      • 23.3.1.2. Product Portfolio
      • 23.3.1.3. Sales Footprint
      • 23.3.1.4. Key Financials
      • 23.3.1.5. SWOT Analysis
      • 23.3.1.6. Key Developments
      • 23.3.1.7. Strategy Overview
        • 23.3.1.7.1. Channel Strategy
        • 23.3.1.7.2. Marketing Strategy
        • 23.3.1.7.3. Product Strategy
    • 23.3.2. Blue Earth Diagnostics
      • 23.3.2.1. Company Overview
      • 23.3.2.2. Product Portfolio
      • 23.3.2.3. Sales Footprint
      • 23.3.2.4. Key Financials
      • 23.3.2.5. SWOT Analysis
      • 23.3.2.6. Key Developments
      • 23.3.2.7. Strategy Overview
        • 23.3.2.7.1. Channel Strategy
        • 23.3.2.7.2. Marketing Strategy
        • 23.3.2.7.3. Product Strategy
    • 23.3.3. Lantheus
      • 23.3.3.1. Company Overview
      • 23.3.3.2. Product Portfolio
      • 23.3.3.3. Sales Footprint
      • 23.3.3.4. Key Financials
      • 23.3.3.5. SWOT Analysis
      • 23.3.3.6. Key Developments
      • 23.3.3.7. Strategy Overview
        • 23.3.3.7.1. Channel Strategy
        • 23.3.3.7.2. Marketing Strategy
        • 23.3.3.7.3. Product Strategy
    • 23.3.4. Siemens Healthcare Private Limited
      • 23.3.4.1. Company Overview
      • 23.3.4.2. Product Portfolio
      • 23.3.4.3. Sales Footprint
      • 23.3.4.4. Key Financials
      • 23.3.4.5. SWOT Analysis
      • 23.3.4.6. Key Developments
      • 23.3.4.7. Strategy Overview
        • 23.3.4.7.1. Channel Strategy
        • 23.3.4.7.2. Marketing Strategy
        • 23.3.4.7.3. Product Strategy
    • 23.3.5. GE Healthcare
      • 23.3.5.1. Company Overview
      • 23.3.5.2. Product Portfolio
      • 23.3.5.3. Sales Footprint
      • 23.3.5.4. Key Financials
      • 23.3.5.5. SWOT Analysis
      • 23.3.5.6. Key Developments
      • 23.3.5.7. Strategy Overview
        • 23.3.5.7.1. Channel Strategy
        • 23.3.5.7.2. Marketing Strategy
        • 23.3.5.7.3. Product Strategy
    • 23.3.6. Advanced Accelerator Applications (Novartis)
      • 23.3.6.1. Company Overview
      • 23.3.6.2. Product Portfolio
      • 23.3.6.3. Sales Footprint
      • 23.3.6.4. Key Financials
      • 23.3.6.5. SWOT Analysis
      • 23.3.6.6. Key Developments
      • 23.3.6.7. Strategy Overview
        • 23.3.6.7.1. Channel Strategy
        • 23.3.6.7.2. Marketing Strategy
        • 23.3.6.7.3. Product Strategy
    • 23.3.7. University of Lowa HealthCare
      • 23.3.7.1. Company Overview
      • 23.3.7.2. Product Portfolio
      • 23.3.7.3. Sales Footprint
      • 23.3.7.4. Key Financials
      • 23.3.7.5. SWOT Analysis
      • 23.3.7.6. Key Developments
      • 23.3.7.7. Strategy Overview
        • 23.3.7.7.1. Channel Strategy
        • 23.3.7.7.2. Marketing Strategy
        • 23.3.7.7.3. Product Strategy
    • 23.3.8. Telix Pharmaceuticals Limited
      • 23.3.8.1. Company Overview
      • 23.3.8.2. Product Portfolio
      • 23.3.8.3. Sales Footprint
      • 23.3.8.4. Key Financials
      • 23.3.8.5. SWOT Analysis
      • 23.3.8.6. Key Developments
      • 23.3.8.7. Strategy Overview
        • 23.3.8.7.1. Channel Strategy
        • 23.3.8.7.2. Marketing Strategy
        • 23.3.8.7.3. Product Strategy
    • 23.3.9. Jubilant Radiopharma
      • 23.3.9.1. Company Overview
      • 23.3.9.2. Product Portfolio
      • 23.3.9.3. Sales Footprint
      • 23.3.9.4. Key Financials
      • 23.3.9.5. SWOT Analysis
      • 23.3.9.6. Key Developments
      • 23.3.9.7. Strategy Overview
        • 23.3.9.7.1. Channel Strategy
        • 23.3.9.7.2. Marketing Strategy
        • 23.3.9.7.3. Product Strategy
    • 23.3.10. TRASIS
      • 23.3.10.1. Company Overview
      • 23.3.10.2. Product Portfolio
      • 23.3.10.3. Sales Footprint
      • 23.3.10.4. Key Financials
      • 23.3.10.5. SWOT Analysis
      • 23.3.10.6. Key Developments
      • 23.3.10.7. Strategy Overview
        • 23.3.10.7.1. Channel Strategy
        • 23.3.10.7.2. Marketing Strategy
        • 23.3.10.7.3. Product Strategy
    • 23.3.11. RadioMedix Inc.
      • 23.3.11.1. Company Overview
      • 23.3.11.2. Product Portfolio
      • 23.3.11.3. Sales Footprint
      • 23.3.11.4. Key Financials
      • 23.3.11.5. SWOT Analysis
      • 23.3.11.6. Key Developments
      • 23.3.11.7. Strategy Overview
        • 23.3.11.7.1. Channel Strategy
        • 23.3.11.7.2. Marketing Strategy
        • 23.3.11.7.3. Product Strategy
    • 23.3.12. IBA Radiopharma Solutions
      • 23.3.12.1. Company Overview
      • 23.3.12.2. Product Portfolio
      • 23.3.12.3. Sales Footprint
      • 23.3.12.4. Key Financials
      • 23.3.12.5. SWOT Analysis
      • 23.3.12.6. Key Developments
      • 23.3.12.7. Strategy Overview
        • 23.3.12.7.1. Channel Strategy
        • 23.3.12.7.2. Marketing Strategy
        • 23.3.12.7.3. Product Strategy
    • 23.3.13. Piramal Imaging (Life Molecular Imaging)
      • 23.3.13.1. Company Overview
      • 23.3.13.2. Product Portfolio
      • 23.3.13.3. Sales Footprint
      • 23.3.13.4. Key Financials
      • 23.3.13.5. SWOT Analysis
      • 23.3.13.6. Key Developments
      • 23.3.13.7. Strategy Overview
        • 23.3.13.7.1. Channel Strategy
        • 23.3.13.7.2. Marketing Strategy
        • 23.3.13.7.3. Product Strategy
    • 23.3.14. Cardinal Health
      • 23.3.14.1. Company Overview
      • 23.3.14.2. Product Portfolio
      • 23.3.14.3. Sales Footprint
      • 23.3.14.4. Key Financials
      • 23.3.14.5. SWOT Analysis
      • 23.3.14.6. Key Developments
      • 23.3.14.7. Strategy Overview
        • 23.3.14.7.1. Channel Strategy
        • 23.3.14.7.2. Marketing Strategy
        • 23.3.14.7.3. Product Strategy
    • 23.3.15. DuchemBio, Co., Ltd
      • 23.3.15.1. Company Overview
      • 23.3.15.2. Product Portfolio
      • 23.3.15.3. Sales Footprint
      • 23.3.15.4. Key Financials
      • 23.3.15.5. SWOT Analysis
      • 23.3.15.6. Key Developments
      • 23.3.15.7. Strategy Overview
        • 23.3.15.7.1. Channel Strategy
        • 23.3.15.7.2. Marketing Strategy
        • 23.3.15.7.3. Product Strategy

24. Assumptions and Acronyms Used

25. Research Methodology